| Oncogenic pathway signatures in human cancers as a guide to targeted therapies AH Bild, G Yao, JT Chang, Q Wang, A Potti, D Chasse, MB Joshi, ... Nature 439 (7074), 353-357, 2006 | 2362 | 2006 |
| Predicting the clinical status of human breast cancer by using gene expression profiles M West, C Blanchette, H Dressman, E Huang, S Ishida, R Spang, H Zuzan, ... Proceedings of the national academy of Sciences 98 (20), 11462-11467, 2001 | 1763 | 2001 |
| Gene expression predictors of breast cancer outcomes E Huang, SH Cheng, H Dressman, J Pittman, MH Tsou, CF Horng, A Bild, ... The Lancet 361 (9369), 1590-1596, 2003 | 832 | 2003 |
| A genomic strategy to refine prognosis in early-stage non–small-cell lung cancer A Potti, S Mukherjee, R Petersen, HK Dressman, A Bild, J Koontz, ... New England Journal of Medicine 355 (6), 570-580, 2006 | 707 | 2006 |
| Genomic signatures to guide the use of chemotherapeutics A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ... Nature medicine 12 (11), 1294-1300, 2006 | 696 | 2006 |
| Standardizing global gene expression analysis between laboratories and across platforms Toxicogenomics Research Consortium Weis BK weis@ niehs. nih. gov 1 b Nature methods 2 (5), 351-356, 2005 | 607 | 2005 |
| Gene expression profiling and genetic markers in glioblastoma survival JN Rich, C Hans, B Jones, ES Iversen, RE McLendon, BKA Rasheed, ... Cancer research 65 (10), 4051-4058, 2005 | 377 | 2005 |
| Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers A Berchuck, ES Iversen, JM Lancaster, J Pittman, J Luo, P Lee, S Murphy, ... Clinical cancer research 11 (10), 3686-3696, 2005 | 326 | 2005 |
| Gene expression phenotypic models that predict the activity of oncogenic pathways E Huang, S Ishida, J Pittman, H Dressman, A Bild, M Kloos, M D'Amico, ... Nature genetics 34 (2), 226-230, 2003 | 324 | 2003 |
| An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer HK Dressman, A Berchuck, G Chan, J Zhai, A Bild, R Sayer, J Cragun, ... Journal of clinical oncology 25 (5), 517-525, 2007 | 304 | 2007 |
| Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes J Pittman, E Huang, H Dressman, CF Horng, SH Cheng, MH Tsou, ... Proceedings of the National Academy of Sciences 101 (22), 8431-8436, 2004 | 280 | 2004 |
| MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis T Boren, Y Xiong, A Hakam, R Wenham, S Apte, ZZ Wei, S Kamath, ... Gynecologic oncology 110 (2), 206-215, 2008 | 246 | 2008 |
| Gene expression signatures that predict radiation exposure in mice and humans HK Dressman, GG Muramoto, NJ Chao, S Meadows, D Marshall, ... Plos medicine 4 (4), e106, 2007 | 231 | 2007 |
| Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction JR Nevins, ES Huang, H Dressman, J Pittman, AT Huang, M West Human molecular genetics 12 (suppl_2), R153-R157, 2003 | 200 | 2003 |
| Gene expression phenotypes of atherosclerosis D Seo, T Wang, H Dressman, EE Herderick, ES Iversen, C Dong, K Vata, ... Arteriosclerosis, thrombosis, and vascular biology 24 (10), 1922-1927, 2004 | 179 | 2004 |
| MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy T Boren, Y Xiong, A Hakam, R Wenham, S Apte, G Chan, SG Kamath, ... Gynecologic oncology 113 (2), 249-255, 2009 | 173 | 2009 |
| The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants AB Dohlman, DA Mendoza, S Ding, M Gao, H Dressman, ID Iliev, ... Cell host & microbe 29 (2), 281-298. e5, 2021 | 163 | 2021 |
| Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy HK Dressman, C Hans, A Bild, JA Olson, E Rosen, PK Marcom, ... Clinical Cancer Research 12 (3), 819-826, 2006 | 163 | 2006 |
| Phase I trial of sequential low-dose 5-aza-2′-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma JA Gollob, CJ Sciambi, BL Peterson, T Richmond, M Thoreson, K Moran, ... Clinical Cancer Research 12 (15), 4619-4627, 2006 | 161 | 2006 |
| Gene microarray analysis of human brain arteriovenous malformations T Hashimoto, MT Lawton, G Wen, GY Yang, T Chaly Jr, CL Stewart, ... Neurosurgery 54 (2), 410-425, 2004 | 156 | 2004 |
Mike WestDuke UniversityVerified email at nc.rr.com
